Monday, May 22, 2017 9:57:07 AM
Also...
***Since about when the CEO took over, and from June 30 2016 until March 31, 2017, there have been the SAME amount of common shares.
"As at March 31, 2017, and June 30, 2016, 464,667,527 shares of the Company’s common stock were issued and outstanding, respectively"
***Further, the Q states that as of MAY 9, 2017, there are the SAME number of common shares.
"Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 464,667,527 shares outstanding as of May 9, 2017."
SO, for nearly a year, from at least June 30, 2016 until now, common shares outstanding have remained the same. I didn't calculate the exact conversion and I don't care, but I do know the "dilution" occurred between March 31 and June 30 in the final quarter of the fiscal year, and it had a lot to do with an existing convertible note executed long before this past year. Now its out of the way.
Warning: I Pick Stocks w/ a Magic 8 Ball. Everything I post
could be completely wrong... and occasionally offensive.
Read and absorb my insanity at your own risk.
Recent APYP News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/26/2024 04:13:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/14/2024 02:29:42 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/08/2024 08:13:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/16/2023 05:24:36 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/13/2023 11:29:06 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:43:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 12:53:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/28/2023 08:47:30 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/28/2023 08:46:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:05:20 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM